Exact Sciences‘ Cologuard, which received its FDA approval last month, will be offered to Group Health Cooperative patients, the organization announced recently.

GHC will be the first health plan in Wisconsin to offer Cologuard, a noninvasive screening test for colorectal cancer.

“Exact Sciences is proud to be a Wisconsin-based company, making it especially fitting that one of the first health plans and clinics in the country to offer and cover Cologuard be in our own backyard,” Exact Sciences President, CEO and Chairman Kevin Conroy said in a statement. “We look forward to working with Group Health Cooperative to give patients in Wisconsin access to this important new cancer screening technology.”

According to a release, Cologuard will be available to GHC patients through their current laboratory benefits as prescribed by their primary care physicians.